US sanctions force vessels with Russian oil to divert from India, sources say
The U.S. Treasury Department this week imposed sanctions on more than 115 Iran-linked individuals, entities, and ships, some of which are involved in transporting Russian oil.
U.S. President Donald Trump has urged countries to halt purchases of oil from Moscow, threatening 100% tariffs unless Russia agrees to a significant peace deal with Ukraine.
Three ships - the Aframaxes Tagor and Guanyin and the Suezmax Tassos - were scheduled to deliver Russian oil to Indian ports this month, trade sources said. All three vessels are under U.S. sanctions.
Tagor was bound for Chennai on India's east coast, while Guanyin and Tassos were headed to ports in western India, according to trade sources and Russian ports data.
US sanctions strand Iran, Russia oil on tankers, driving up crude costs
Tighter Western sanctions aimed at cutting Russia's oil revenue, seen as funding its war against Ukraine, have been increasingly hitting Russian oil supplies for India, which buys more than a third of its oil needs from Russia.
Tagor is now heading to Dalian in China, while Tassos is diverting to Port Said in Egypt, the data shows.
Guanyin remains on course to Sikka, a port used by Reliance Industries and Bharat Petroleum Corp Ltd..
Indian Oil Corp, which was to receive the Tagor shipment, and BPCL did not respond to Reuters' emailed requests for comment.
Zulu Shipping, linked to Panama-flagged Tassos and Tagor, and Guanyin-owner Silver Tetra Marine could not be reached for comments. Both companies are under U.S. sanctions.
A Reliance spokesperson said that 'neither of these two vessels, Guanyin and Tassos, is coming to us'.
Reliance has previously purchased oil in Guanyin.
Separately, two other vessels, Achilles and Elyte, loaded with Russian oil, are preparing to discharge Russian Urals for Reliance, according to LSEG data. Both these vessels are sanctioned by Britain and the European Union. India has condemned the EU sanctions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
5 minutes ago
- Business Recorder
Russian, Chinese navies to conduct joint patrols in Asia-Pacific, Interfax reports
Russian and Chinese naval vessels will conduct joint patrols in the Asia-Pacific following recent exercises in the Sea of Japan, Russia's Interfax reported on Wednesday. 'Crews of the Russian Navy and China's PLA Navy will form a new task group to carry out joint patrol missions in the Asia-Pacific region,' Interfax said, citing a statement from the Russian Pacific Fleet's press service. The two navies held joint drills in the Sea of Japan over Aug 1-5 that included artillery firing, practising anti-submarine and air defence missions, and improving joint search and rescue operations at sea. During the final phase of the exercises, Russian large anti-submarine ship Admiral Tributs and corvette Gromky, together with Chinese destroyers Shaoxing and Urumqi, carried out live-fire training drills and crews practiced searching for and neutralising a mock enemy submarine, Interfax reported. The Pacific Fleet earlier said that the drills were defensive in nature and not directed against any other countries. Russia and China, which signed a 'no-limits' strategic partnership shortly before Russia went to war in Ukraine in 2022, conduct regular exercises to rehearse coordination between their armed forces and send a deterrent signal to adversaries.
Business Recorder
5 minutes ago
- Business Recorder
US tariff threat to keep Indian rupee on the ropes ahead of RBI rate call
MUMBAI: The Indian rupee is likely to remain under pressure ahead of the central bank's interest rate decision on Wednesday, after nearing an all-time low following President Donald Trump's fresh threats of steep tariffs on Indian goods. The 1-month non-deliverable forward suggests the rupee will open slightly weaker against the U.S. dollar from Tuesday's level of 87.80. The currency dropped as much as 87.8850 on Tuesday, just shy of its record low of 87.95 hit in February. Bankers said the rupee avoided hitting a fresh lifetime low, thanks to likely dollar sales by the Reserve Bank of India through state-run banks. The central bank had to step in after the rupee slid following Trump's threat of substantial tariffs on Indian goods over Russian oil purchases. 'The RBI probably wanted to avoid headlines about the rupee hitting a new low on the same day Trump was ramping up tariffs,' an FX trader at a private bank said. '87.90–88 is the key zone to watch. If the RBI does cut rates today, we'll most likely break past that, and the central bank may allow some weakness.' About three-quarters of the 57 participants in a Reuters poll expect the RBI to leave the policy rate unchanged at 5.50%. The rest anticipate a 25-basis point cut, following a larger-than-expected 50-bp reduction in June. Citibank, ANZ, DBS, State Bank of India and ICICI Bank are among those expecting a rate cut. At the previous policy, SBI was the only one to predict a 50-bps reduction. Monetary policy operates with lags, and postponing a rate cut until inflation falls further or growth weakens more visibly could result in deeper and more persistent economic damage, SBI said in a note. 'We expect RBI to continue frontloading with a 25 bps cut in August policy.'
Business Recorder
5 minutes ago
- Business Recorder
US to initially impose ‘small tariff' on pharma imports, Trump says
WASHINGTON: President Donald Trump said on Tuesday that the United States would initially place a 'small tariff' on pharmaceutical imports before hiking it to 150% within 18 months and eventually to 250% in an effort to boost domestic production. 'In one year, one and a half years maximum, it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country,' Trump told CNBC in an interview. He did not specify the initial tariff rate on pharmaceuticals. Trump said last month that pharmaceutical tariffs could reach as high as 200%. He said in February that sectoral tariffs on pharmaceuticals and semiconductor chips would start at '25% or higher,' rising substantially over the course of a year. Trump said on Tuesday that he plans to announce tariffs on semiconductors and chips in the 'next week or so,' but gave no further details. The United States has been conducting a national security review of the pharmaceutical sector, and the industry has been preparing for possible sector-specific tariffs. The administration has not announced when the results of that probe will be released. Several drugmakers have pledged multibillion-dollar investments in US manufacturing as Trump threatens import tariffs, with AstraZeneca recently committing $50 billion to expand its American operations. PhRMA, the main lobbying group for the industry, did not immediately respond to a request for comment. A framework agreement between the United States and the EU sets out that tariffs on pharmaceuticals and semiconductors are currently zero, but if the United States raises tariffs following its import investigation, they will be capped at 15%.
